Research suggests that the available studies linked to ginger's use as a food-form anti-inflammatory do not directly examine this relationship. The three studies on file are observational, qualitative, or epidemiological in nature and focus primarily on COVID-19 outcomes, persistent post-COVID sensory loss, and patient recovery experiences, none of which were designed to test ginger's anti-inflammatory properties specifically or isolate its effects. While one exploratory study examined associations between common Indian spice consumption patterns — including ginger — and COVID-19 statistics across Indian states, it found no statistically significant connection for ginger and the authors themselves cautioned against drawing firm conclusions. Overall, the current body of linked evidence does not provide meaningful support for or against ginger in food form as an anti-inflammatory agent, and readers interested in this topic would need to consult studies designed specifically to assess that question.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Relation of spice consumption with COVID-19 first wave statistics (infection,... | Other | 2022 | Neutral | 90 |
| Clinical Characteristics and Long-term Symptomology of Post-COVID-19 Olfactor... | Other | 2023 | Neutral | 85 |
| Experiences of COVID-19 Recovered Patients – A Qualitative Case Study from a ... | Other | 2021 | Neutral | 80 |